Cyrille Leperlier
Vermogen: - $ op 31-03-2024
Vermogen: - $ op 31-03-2024
Cyrille Raymond George Leperlier is currently an Independent Non-Executive Director at NuCana Plc since 2018.
Formerly, the role of Chief Executive Officer was held at Divlal SAS from 2020 to 2022.
The position of Medical Director was held at Rhone-Poulenc Rorer, Inc. Medical Director at Sanofi-Aventis Japan was held from 2014 to 2019.
Education includes graduate and doctorate degrees from the University of Paris Jussieu.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NUCANA PLC -.--% | 18-03-2026 | 0 ( -.--% ) | - $ | 31-03-2024 |
| Bedrijven | Functie | Begin |
|---|---|---|
| NUCANA PLC | Directeur/Bestuurslid | 01-05-2018 |
| Bedrijven | Functie | Einde |
|---|---|---|
Divlal SAS | Algemeen Directeur | 01-11-2022 |
Sanofi-Aventis Japan | Hoofd Techniek/Wetenschap/O&O | 01-12-2019 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
University of Paris Jussieu
University of Paris Jussieu Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis Japan | |
NuCana Plc
NuCana Plc BiotechnologyHealth Technology Develops and commercializes novel anti-cancer medicines | Health Technology |
Divlal SAS |
Kies jouw editie
Alle financiële informatie op nationaal niveau